Menu Close

Application Deadline: Clinical Research Scholars Program (KL2)

Application Deadline: Friday, December 9, 2022

View the Call for Applications

KL2 Mentored Career Development Awards support the career development of faculty members dedicated toward a career in clinical investigation by offering up to $110,000 in annual salary support and up to $30,000 towards the cost of a degree, research related expenses, travel, and/or other related activities.

Information Session

https://jhjhm.zoom.us/rec/play/ZycIwDQtiJO-dVhYk_vESidCmjuXqtjemiv1L8cKX-9aZGQyaZMSg9TiB8N7lysxeRcqTVwlMba20KdI.3slS6JbsimHlM0NW

Passcode: Ne@1%HB0


Each scholar is provided with the following funding as a KL2 scholar (subject to change). NIH funded support is provided for a maximum of 2 years (24 months). If needed, a scholar will begin coverage under their department at the beginning of year 3.

  • Salary support up to $110,000 (for 75-90% effort) plus fringe
  • Up to $18,000 for tuition support plus $850 for fees
  • Research support varies per year based on funding. Usually between $5,000 – $8,000
  • Scholarly travel support up to $2,500 to support attendance to the annual ACTS conference and other travel related to the KL2 award

Funding for 2023-2024 is expected to be provided for 2 scholars through April 30, 2024. NIH funding will be provided for 1 scholar with a May 1, 2023 start and a 2nd scholar for a July 1, 2023 start.

Applications must include all components and supporting documents to be considered complete. It is the applicant’s responsibility to prepare and collect each component and to monitor the status of their application. We recommended that applicants complete the recommendation section of their application early, to send request to their recommenders, and then continue to work on their application. Incomplete or late applications will not be considered.

Date

December 09, 2022
Expired!

Time

4:00 pm - 5:00 pm

More Info

More Information

Organizer

Karla McCarthy
Phone
410-502-8840
Email
[email protected]
More Information